COMMUNIQUÉS West-GlobeNewswire

Onconetix Highlights Realbotix’s Launch of Humanoid Robot and AI Teachers Assistant Pilot Program in New York State School District
24/06/2026
Salamanca City Central School District on Seneca Nation Reservation to Deploy Optio and Realbotix M-Series Humanoid Robot; Pilot to Expand to Approximately 500 High School Students in Fall 2026; Onconetix Recently [...]
Profusa Shareholders Approve Strategic Initiatives at 2026 Annual Meeting, Supporting PanOmics Acquisition, Balance Sheet Strengthening and Nasdaq Compliance Efforts
24/06/2026
BERKELEY, Calif., June 24, 2026 (GLOBE NEWSWIRE) -- Profusa, Inc. (Nasdaq: PFSA), a digital health company pioneering next-generation biosensing technologies, announces that shareholders approved all proposals presented [...]
EchoIQ Strengthens Leadership Team and Clinical Advisory Network to Accelerate Next Phase of Commercial Growth and U.S. FDA Initiatives
24/06/2026
Matthew Dodds appointed Chief Financial Officer, bringing over 30 years of healthcare, medical technology, capital markets, corporate development and investor relations experience Dr. Vinod Thourani appointed Clinical [...]
Helus Pharma™ Announces US$50 Million Underwritten Offering
24/06/2026
NEW YORK and TORONTO, June 24, 2026 (GLOBE NEWSWIRE) -- Helus Pharma™ (Nasdaq: HELP) (Cboe CA: HELP) (the “ Company ” or “ Helus Pharma ”), a clinical stage pharmaceutical company committed to helping minds heal by [...]
Response Biomedical Expands Global Diagnostics Portfolio with the Launch of the RAMP Xpress
24/06/2026
Expands Response Biomedical beyond acute care into chronic disease and wellness testing Introduces a next-generation platform for metabolic and inflammatory biomarker testing Combines speed, portability, and workflow [...]
Cognition Therapeutics Aligns on Key Aspects of Pivotal Study for Zervimesine (CT1812) in DLB Psychosis Following Receipt of FDA Meeting Minutes
24/06/2026
- Zervimesine Would be the First Long-term, Durable Treatment Option with an Impact on Underlying Disease - - Company Developing NPI as a Measure of DLB Psychosis - PURCHASE, N.Y., June 24, 2026 (GLOBE NEWSWIRE) -- [...]
AIM ImmunoTech Accelerates Toward Potential Pivotal Pancreatic Cancer Program as Ampligen Continues to Advance Through Key Clinical Milestones
24/06/2026
Recent Clinical Progress, Enrollment Achievements, Expanded Intellectual Property Portfolio and Strengthened Financial Position Support a Potentially Transformative 12-Month Value Creation Opportunity OCALA, Fla., June [...]
RQ Bio Announces $115 Million (£85.5 Million) Series A Financing to Advance Long-Acting Antibody Programme RQB01 for Full Season Influenza Prevention
24/06/2026
Financing led by Frazier Life Sciences with participation from new investors EQT Life Sciences, Forbion, Monograph , Wellington Management and founding investor LifeArc Ventures Proceeds support clinical development of [...]
FEATOL Introduces Anti-Fatigue Mat Designed to Improve Comfort During Long Hours of Standing
24/06/2026
NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- FEATOL, a brand specializing in ergonomic support and protective products, has introduced its Anti Fatigue Mat , designed to help reduce the discomfort and fatigue commonly [...]
uniQure Announces Pricing of Upsized $225 Million Public Offering
24/06/2026
LEXINGTON, Mass. and AMSTERDAM, June 23, 2026 (GLOBE NEWSWIRE) -- uniQure N.V. (Nasdaq: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced [...]
MoonLake Immunotherapeutics Announces Pricing of Upsized $200 Million Public Offering
24/06/2026
ZUG, Switzerland , June 23, 2026 – MoonLake Immunotherapeutics (NASDAQ: MLTX) (“MoonLake”), a clinical-stage biotechnology company focused on creating next-level therapies for inflammatory skin and joint diseases, today [...]
TWL Announces Expanded Online Access to GLP-1 Weight-Loss Care With Insurance and Self-Pay Options
24/06/2026
Telehealth program combines licensed medical care, insurance coordination, coaching and multiple prescription pathways for eligible patients New York, NY, June 23, 2026 (GLOBE NEWSWIRE) -- TWL today announced an [...]
Glass House Brands Provides Notice of Warrant Acceleration
24/06/2026
LONG BEACH, Calif. and TORONTO, June 23, 2026 (GLOBE NEWSWIRE) -- Glass House Brands Inc. ("Glass House" or the "Company") (CBOE CA: GLAS.A.U) (OTCQX: GLASF) today announced that it has elected to exercise its rights [...]
MSK Masters Announces Release of Sonography of the Extremities - Techniques and Protocols, 5th Edition
23/06/2026
New edition expands interactive learning resources, updated imaging, and practical tools for musculoskeletal ultrasound professionals SUNMAN, IN, June 23, 2026 (GLOBE NEWSWIRE) -- MSK Masters has announced the release [...]
Artiva Biotherapeutics to Participate in the H.C. Wainwright 4th Annual Cell Therapy Virtual Conference
23/06/2026
SAN DIEGO, June 23, 2026 (GLOBE NEWSWIRE) -- Artiva Biotherapeutics, Inc. (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients [...]
Agomab Announces Design of NOV-ERA Phase 2b Study with Ontunisertib in Fibrostenosing Crohn’s Disease
23/06/2026
-- Regulatory alignment with U.S. Food and Drug Administration (FDA) on key elements of NOV-ERA Phase 2b study design, including novel primary endpoint of endoscopic passability -- -- Study initiation on track, with [...]
'Possibilities' Premieres June 27, Reimagining Accessible Filmmaking Through Collaboration Between Blind, Low-Vision, and Sighted Creatives
23/06/2026
Feature-length documentary integrating open audio description launches at in Zankel Hall at Carnegie Hall and on streaming platforms worldwide NEW YORK, June 23, 2026 (GLOBE NEWSWIRE) -- A new documentary premiering [...]
Coherus and Zumutor Biologics Announce Clinical Collaboration to Evaluate ZM008 in Combination with LOQTORZI® (toripalimab-tpzi)
23/06/2026
– First patient dosed in a Phase 1 study evaluating ZM008, an anti-LLT1 mAb, in combination with LOQTORZI, a next-generation PD-1 inhibitor – REDWOOD CITY, Calif., June 23, 2026 (GLOBE NEWSWIRE) -- Coherus Oncology, Inc [...]
Acquisition of Own Shares
23/06/2026
Mechelen, Belgium; 23 June 2026, 22.01 CET; regulated information Within the framework of the repurchase program announced on June 9, 2026, Lakefront Biotherapeutics NV (Euronext & NASDAQ: LKFT) ("Lakefront") [...]

Pages